Vivet, Therapeutics Vivet Therapeutics Presents Interim Data from its Phase 1 / 2 GATEWAY Trial for the Treatment of Wilson Disease at EASL Congress 2024 07.08.2025 - 18:04:35 Vivet Therapeutics United Kingdom United States of America France Italy View original content:https://www.prnewswire.co.uk/news-releases/vivet-therapeutics-presents-interim-data-from-its-phase-12-gateway-trial-for-the-treatment-of-wilson-disease-at-easl-congress-2024-302164669.html
